Patient-perceived benefit during one year of treatment with Doloteffin®

Phytomedicine

Volumn 14, Issue 6, 2007, Pages 371-376

  Chrubasik, S ^a,b   Chrubasik, C ^a   Kunzel O ^a   Black, A ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Hip; Knee; Lower back; Osteoarthritic pain; stand. Harpagophytum extract; Survey

Indexed keywords

ACEMETACIN; ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; DIHYDROCODEINE; DIPYRONE; DOLOTEFFIN; HARPAGOSIDE; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROPYPHENAZONE; ROFECOXIB; UNCLASSIFIED DRUG;

ADULT; AGED; ANALGESIA; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL FEATURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; FUNCTIONAL STATUS; HEADACHE; HEALTH ASSESSMENT QUESTIONNAIRE; HIP DISEASE; HIP OSTEOARTHRITIS; HUMAN; INTENTION TO TREAT; KNEE OSTEOARTHRITIS; KNEE PAIN; LAST VALUE CARRIED FORWARD; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS OF VARIANCE; OSTEOARTHRITIS; PAIN ASSESSMENT; PARAMETER; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RATING SCALE; RECOMMENDED DRUG DOSE; TREATMENT OUTCOME;

AGED; BACK PAIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN; PATIENT SATISFACTION; PHYTOTHERAPY; PLANT EXTRACTS;

HARPAGOPHYTUM;

EID: 34249277054     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2007.04.011     Document Type: Article

References (13)

1. Blumenthal, M., 1998. The Complete German Commission E Monographs, pp. 120-121.
2. Chrubasik, J.E., Roufogalis, B., Chrubasik, S., 2006. Systematic review on the safety of Harpagophytum preparations for osteoarthritic or low back pain. Focus on Alternative and Complementary Therapies 11 (Suppl. 1) 12 (13th Annual Symposium on Complementary Health Care, Exeter).
3. Chrubasik S., Zimpfer Ch., Schütt U., and Ziegler R. Effectiveness of Harpagophytum procumbens in treatment of acute low back pain. Phytomedicine 3 (1996) 1-10
4. Chrubasik S., Junck H., Breitschwerdt H., Conradt C., and Zappe H. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized placebo-controlled double-blind study. Eur. J. Anaesthesiol. 16 (1999) 118-129
5. ®. Phytomedicine 9 (2002) 181-194
6. Chrubasik S., Conradt C., and Black A. The quality of clinical trials with Harpagophytum procumbens. Phytomedicine 10 (2003) 613-623
7. Chrubasik S., Model A., Pollak S., and Black A. A randomised double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology 42 (2003) 141-148
8. ® for low back pain. Phytomedicine 11 (2005) 470-477
9. Fordyce, W.E., 1995. Back pain in the workplace: management of disability in nonspecific conditions. A Report of the Task Force on Pain in the Workplace of the International Association for the Study of pain, IASP Press, Seattle.
10. Gagnier J., Vantulder M., Berman B., and Bombardier C. Herbal medicine for low back pain. Cochrane Database Syst. Rev. 2 (2006) CD004504
11. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., Simon L., Strand V., Woodworth T., Dougados M., and OMERACT-OARSI initiative. Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 12 (2004) 389-399
12. Robinson V., Boers M., Brooks P., Francis D., Judd M., McGowan J., Shea B., Simon L.S., Strand V., Tugwell P., and Wells G.A. Patient-reported pain is central to OMERACT rheumatology core measurement sets. Drug Inform. J. 40 (2006) 111-116
13. Sporer F., and Chrubasik S. Präparate aus der Teufelskralle (Harpagophytum procumbens) (1999). Z. Phytotherapie 20 (1999) 235-236